How to join?

We are looking to recruit over 3000 participants for the CaPP3 Study and would like to involve as many interested parties as possible. If you are interested in joining the trial please fill in the form below and we will contact when the trial is ready for enrollment.

Participant Registration

To show interest in participating in the trial please enter your details below.

  • The following fields are all optional. We are looking to gauge interest in the trial at the moment and any information you provide will be used to contact you in the future to discuss the trial and how to sign up.

Find Out More

Latest News

Downloads

  • CAPP2 protocol

    posted on Tuesday, 9th October 2012

  • CAPP2 Paper October 2011

    posted on Thursday, 27th October 2011

    Research has finally provided proof that taking a regular dose of aspirin reduces the long-term risk of cancer in people with a family history of the disease by around 60 per cent.